Cargando…
In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
BACKGROUND: Aberrant methylation is a frequent event in oral cancer. METHODS: In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further...
Autores principales: | Pereira, Cláudia Maria, de Carvalho, Ana Carolina, da Silva, Felipe Rodrigues, Melendez, Matias Eliseo, Lessa, Roberta Cardim, Andrade, Valéria Cristina C., Kowalski, Luiz Paulo, Vettore, André L., Carvalho, André Lopes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816396/ https://www.ncbi.nlm.nih.gov/pubmed/29454310 http://dx.doi.org/10.1186/s12885-018-4077-3 |
Ejemplares similares
-
Evaluation of acetylation and methylation in oral rinse of patients with head and neck cancer history exposed to valproic acid
por: Gama, Ricardo Ribeiro, et al.
Publicado: (2021) -
TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors
por: Rettori, Marianna Marconato, et al.
Publicado: (2013) -
Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma
por: Maia, Danielle, et al.
Publicado: (2015) -
Second primary tumor in patients with upper aerodigestive tract cancer
por: Priante, Antonio Vitor Martins, et al.
Publicado: (2015) -
The Roles of FHL3 in Cancer
por: Huang, Zhenjun, et al.
Publicado: (2022)